Medical Genetics Another major blow came in January 2003, when the FDA (USA) placed a temporary halt on all gene therapy trials using retroviral vectors in blood stem cellsMedical Genetics Another major blow came in January 2003, when the FDA (USA) placed a temporary halt on all gene therapy trials using retroviral vectors in blood stem cells